483
Peter O'DonnellPeter O'Donnell – FDA 483, Jan 19, 2017
Record Details
An FDA inspection of Peter O'Donnell in Chicago, IL, revealed significant non-compliance in the conduct of a clinical investigation. The site failed to promptly report serious adverse events to the sponsor and did not adhere to the investigational plan for subject follow-up and adverse event reporting. Additionally, the firm maintained inadequate and inaccurate case histories and failed to provide required financial disclosure statements in a timely manner.
View Company Profile
ID · 17908b6f-2d3c-4151-9228-2ef3b4228770
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.